Integral Health Asset Management, LLC Biomarin Pharmaceutical Inc Transaction History

Integral Health Asset Management, LLC

$850 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$86.68 - $100.3 $4.33 Million - $5.02 Million	-50,000 Reduced 50.0%	50,000 $4.33 Million
Q1 2023 May 09, 2023	SELL	$87.74 - $117.27 $6.14 Million - $8.21 Million	-70,000 Reduced 41.18%	100,000 $9.72 Million
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $5.1 Million - $6.84 Million	63,000 Added 58.88%	170,000 $17.6 Million
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $1.58 Million - $1.87 Million	-19,286 Reduced 15.27%	107,000 $9.07 Million
Q2 2022 Aug 03, 2022	BUY	$71.48 - $86.85 $3.31 Million - $4.02 Million	46,286 Added 57.86%	126,286 $10.5 Million
Q1 2022 May 12, 2022	BUY	$74.28 - $92.69 $2.38 Million - $2.97 Million	32,000 Added 66.67%	80,000 $6.17 Million
Q4 2021 Feb 02, 2022	BUY	$71.72 - $91.47 $2.15 Million - $2.74 Million	30,000 Added 166.67%	48,000 $4.24 Million
Q3 2021 Nov 12, 2021	SELL	$74.77 - $85.47 $523,390 - $598,290	-7,000 Reduced 28.0%	18,000 $1.39 Million
Q2 2021 Aug 30, 2021	SELL	$75.51 - $84.79 $1.89 Million - $2.12 Million	-25,000 Reduced 50.0%	25,000 $2.09 Million
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $151,020 - $169,580	-2,000 Reduced 3.85%	50,000 $4.17 Million
Q1 2021 May 10, 2021	SELL	$74.73 - $90.69 $2.47 Million - $2.99 Million	-33,000 Reduced 38.82%	52,000 $3.93 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $2.54 Million - $3.16 Million	-35,000 Reduced 29.17%	85,000 $7.45 Million
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $2.87 Million - $5.24 Million	40,000 Added 50.0%	120,000 $9.13 Million
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $2.39 Million - $3.73 Million	-30,000 Reduced 27.27%	80,000 $9.87 Million
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $7.07 Million - $9.5 Million	110,000 New	110,000 $9.3 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.

Account